Injection/Infusion
BESREMI SOLUTION FOR INJECTION IN PREFILLED SYRINGE 500MCG/1ML
Summary
BESREMI SOLUTION FOR INJECTION IN PREFILLED SYRINGE 500MCG/1ML — Injection/Infusion containing ropeginterferon alfa-2b. Hong Kong Registration No. HK-68864. Certificate Holder: KLN PHARMA (HONG KONG) LIMITED O/B KLN PHARMA (HONG KONG) LIMITED. Date of Registration: 06 Oct, 2025.
Product NameBESREMI SOLUTION FOR INJECTION IN PREFILLED SYRINGE 500MCG/1ML
Registration No.HK-68864
Certificate HolderKLN PHARMA (HONG KONG) LIMITED O/B KLN PHARMA (HONG KONG) LIMITED
Holder AddressROOM D, UNIT 1501, 15/F, KERRY CARGO CENTRE, 55 WING KEI ROAD, KWAI CHUNG, NEW TERRITORIES
Ingredientsropeginterferon alfa-2b
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration06 Oct, 2025
ATC codesL03AB15
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents
All ATC groupsL03
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。